ARTICLE | Company News
Tranzyme Inc. other research news
November 15, 1999 8:00 AM UTC
Tranzyme received a $190,000 Phase I STTR grant from the National Institute of Allergy and Infectious Diseases to develop its TranzAssay cell-based (phenotypic) HIV drug resistance assay and its Tranz...